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SUMMARY
Leishmania infantum causes visceral leishmaniasis (VL) in the New World. The diagnosis of VL is confirmed by parasitological 
and serological tests, which are not always sensitive or specific. Our aim was to design new primers to perform a Polymerase Chain 
Reaction (PCR) for detecting L. infantum. Sequences of the minicircle kinetoplast DNA (kDNA) were obtained from GenBank, and 
the FLC2/RLC2 primers were designed. Samples of DNA from L. infantum, Leishmania amazonensis, Leishmania braziliensis, 
Leishmania guyanensis, Leishmania naiffi, Leishmania lainsoni, Leishmania panamensis, Leishmania major and Trypanosoma cruzi 
were used to standardize the PCR. PCR with FLC2/RLC2 primers amplified a fragment of 230 bp and the detection limit was 0.2 fg of 
L. infantum DNA. Of the parasite species assayed, only L. infantum DNA was amplified. After sequencing, the fragment was aligned 
to GenBank sequences, and showed (99%) homology with L. infantum. In the analysis of blood samples and lesion biopsy from a dog 
clinically suspected to have VL, the PCR detected DNA from L. infantum. In biopsy lesions from humans and dogs with cutaneous 
leishmaniasis, the PCR was negative. The PCR with FLC2/RLC2 primers showed high sensitivity and specificity, and constitutes a 
promising technique for the diagnosis of VL. 
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INTRODUCTION
Visceral leishmaniasis (VL) is an infectious, parasitic disease with a 
worldwide distribution; India, Sudan, Nepal and Brazil account for 90% 
of cases35. In the New World, VL is caused by Leishmania infantum (syn. 
Leishmania chagasi), and in Brazil there were 74,980 cases of VL from 
1990 to 20137. VL is a severe and eventually lethal disease, and produces 
signs and symptoms common to other diseases, making its diagnosis 
complex and time-consuming19.
Confirmation of clinical suspicion of VL is based on clinical, 
epidemiological and laboratory tests. Among the conventional diagnostic 
methods for confirmation of VL are parasitological and serological tests8. 
Parasitological examination can directly demonstrate the presence of 
L. infantum in aspirates from the liver, spleen, lymph nodes and bone 
marrow. However, due to the low sensitivity of direct microscopic 
examination many patients do not receive confirmation of the diagnosis2. 
The serological tests include the indirect immunofluorescence assay 
(IFA) and enzyme-linked immunosorbent assay (ELISA)3,14. However, 
these techniques may produce false negative results and cross-reactions 
with other diseases13,20.
Molecular biology techniques have been proposed as an alternative 
in the diagnosis of VL. The Polymerase Chain Reaction (PCR) enables 
rapid diagnosis of disease, is more sensitive than conventional methods, 
and can help to identify the parasite species27,30. Another advantage is that 
PCR can be performed in different biological samples, such as human 
and canine blood, lymph nodes, buffy coat, canine conjunctival scrapings, 
urine and lesions10,12,16,17,21,24.
In view of the limitations of conventional methods, it is necessary to 
standardize new methodologies for the diagnosis of VL. PCR has proven 
to be a valuable, rapid and sensitive tool, and can identify the parasite 
species in different clinical samples from humans, reservoirs and vectors. 
The aim of this study was to design new primers to perform a PCR for 
detecting L. infantum.
MATERIAL AND METHODS
Design of oligonucleotides: The specific forward and reverse PCR 
primers FLC2 (5’-GTCAGTGTCGGAAACTAATCCGC-3’) and RLC2 
(5’-GGGAAATTGGCCTCCCTGAG-3’) were designed to amplify a 230 
bp segment of the conserved region of the DNA minicircle kinetoplast 
(kDNA) of L. chagasi [GenBank:AF308682 LOCUS] with 716 bp (Fig. 
1). The used sequence to design the primers was analyzed by CLUSTAL 
W (www.ebi.ac.uk) and primer-BLAST 2.0 server (“Basic Alignment 
Search Tool”) of the National Center for Biotechnology Information 
(NCBI) to detect their specificity to the proposed PCR template. 
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Clinical samples: The sensitivity and specificity of primers FLC2/
RLC2 were analyzed in clinical samples: lesion biopsy and blood from a 
dog with clinical suspicion of VL, lesions biopsies from three dogs with 
cutaneous leishmaniasis, and five samples obtained by scraping the edge 
of lesions from humans with cutaneous leishmaniasis. The samples were 
placed in eppendorf vials with 50 μL STE buffer (10 mM TRIS, 1 mM 
EDTA, 0.1 M NaCl, pH 8.0) and stored at -20 ºC for later DNA extraction. 
The present study received approval from the Permanent Committee for 
Ethics in Research involving Humans (Process No. 533/2009) of the 
Universidade Estadual de Maringá. All participants were informed about 
the importance and objectives of the study, and were assured of both 
anonymity and confidentiality. We obtained written informed consent 
from patients who agreed to participate. All procedures involving humans 
were conducted according to protocols approved by the National Health 
Council of the Brazilian Ministry of Health (Resolution No. 196/1996). 
An aliquot of 2 mL of dog blood was added to an equal volume 
of ACD solution (25 mM citric acid, 50 mM sodium citrate, 81 mM 
glucose), and centrifuged at 3,500 g for 10 min. The buffy coat was then 
removed and added to a tube containing ACD and stored at -20 ºC for 
later DNA extraction. 
Two hamsters were inoculated in the footpad with 50 μL of Leishmania 
culture from a lesion and venous blood of a dog with clinical suspicion of 
VL. After seven months, the hamsters were euthanized, and material from 
their regional lymph node was placed in culture medium for the isolation 
of the parasite and later DNA extraction. All procedures involving animals 
followed the Ethical Principles of Animal Experimentation established 
by the Brazilian College of Animal Experimentation (COBEA) and were 
performed according to protocols approved by the Committee for Ethical 
Conduct in Animal Experimentation of the Universidade Estadual de 
Maringá (report 015/2007 on 04/03/2007).
Parasites: L. infantum, Leishmania amazonensis, Leishmania 
braziliensis, Leishmania guyanensis, Leishmania naiffi, Leishmania 
lainsoni, Leishmania panamensis, Leishmania major and Trypanosoma 
cruzi (Y strain) were employed for assessing the specificity and sensitivity 
of PCR. Samples of L. braziliensis from different serodemes obtained 
from dogs and humans in the northwestern of the Parana State were also 
analyzed (Table 1). 
Promastigotes of Leishmania spp. were grown in Medium 199 
(Invitrogen, Paisley, Scotland, UK) supplemented with 1% female 
human urine, 10% fetal-calf serum (Invitrogen, Paisley, Scotland, UK) 
and 2 mM L-glutamine (Gibco-BR, Paisley, Scotland, UK), at 25 °C in 
a B.O.D. incubator (Logen Scientific, Brazil). Epimastigotes of T. cruzi 
were grown in LIT (Liver Infusion Tryptose) at 25 °C. The parasites were 
washed by centrifugation at 1,600 g for 10 min with phosphate-buffered 
saline (PBS) pH 7.2. Parasites were counted in a Neubauer chamber and 
stored at -18 °C until DNA extraction.
DNA preparation: The DNA from scrapings of skin lesions was 
extracted according to VENAZZI et al.33 and from the canine lesion 
biopsy was extracted with a Puregene kit (Gentra, USA). The DNA from 
blood was extracted with guanidine isothiocyanate and phenol34 and the 
DNA from Leishmania isolated from hamsters was obtained by heating22. 
The DNA of Leishmania spp. and T. cruzi was extracted with guanidine 
isothiocyanate and phenol34. The DNA was re-suspended in 50 μL of TE 
buffer (1 M Tris, 0.5 M Na2EDTA, pH 8.0) and stored at -18 °C until use.
The DNA samples were quantified by fluorometry using a Quant-iT™ 
dsDNA BR Assay Kit (Invitrogen, Eugene, OR, USA) and a Qubit™ 
Fluorometer Kit (Invitrogen, USA). 
Polymerase Chain Reaction: For PCR standardization, some 
conditions were tested. The reaction mixture contained 0.5 μM of each 
primer (Invitrogen Life Technologies, Sao Paulo, Brazil), 0.2 mM dNTP 
(Invitrogen, Carlsbad, CA, USA), 1 U Taq DNA polymerase (Invitrogen 
Life Technologies, Sao Paulo, Brazil), 1.5 or 2.0 mM MgCl2, 1X enzyme 
buffer and 2 μL of the DNA sample in a final volume of 25 μL. Ultrapure 
water was used as a negative control. Amplification was performed in a 
thermocycler (Biometra Personal Cycler, Germany) under the following 
conditions: initial denaturation at 95 °C for five min, followed by 30 or 
35 cycles of one min at 95 °C, one min at 56 °C or 58 oC and one min at 
72 °C. After 10 min at 72 °C, the amplified material was maintained at 4 
°C until analysis. The amplified product was analyzed by electrophoresis 
in 2% agarose gel (Invitrogen, Paisley, Scotland, UK) at 10-15 V/cm. 
The gel was stained with ethidium bromide and analyzed under UV 
light in a transilluminator (MacroVue™ UV-20, Hoefer). A 100 bp DNA 
ladder (Invitrogen Life Technologies, São Paulo, Brazil) was used as a 
molecular marker.
Analysis of the sensitivity and specificity of FLC2/RLC2 primers 
in parasites: Assessment of PCR sensitivity (FLC2/RLC2 primers) 
was performed using DNA extracted from L. infantum (MHOM/
BR/1974/PP75) at concentrations of 200 ng to 0.002 fg. To determine 
the specificity, DNA (100 pg) from different species of Leishmania, 
two strains of L. infantum, and T. cruzi were analyzed (Table 1). DNA 
(100 pg) from L. braziliensis (serodemes I, II, III and VII) obtained 
from patients in northwestern Paraná and identified by reactivity with 
monoclonal antibodies at the Instituto Evandro Chagas (Belém, Pará, 
Brazil) was also analyzed.
Analysis of the sensitivity and specificity of primers FLC2/RLC2 
in clinical samples: DNA samples from the blood and lesion of a dog 
with clinical suspicion of VL, living in a VL-endemic area, and DNA 
extracted from Leishmania isolated from hamsters that were inoculated 
with lesions and blood from a dog with clinical suspicion of VL were 
analyzed to assess the sensitivity of the primers. 
DNA samples from lesions of five humans and three dogs, all with a 
Fig. 1 - Leishmania chagasi kinetoplast minicircle DNA, complete sequence (GenBank: 
AF308682 LOCUS) with 716 bp and the primers localization. The underlined bold sequences 
represent the FLC2/RLC2 primers.
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confirmed diagnosis of cutaneous leishmaniasis [direct parasite search, 
IFA and PCR Leishmania (Viannia)] were also analyzed to verify the 
specificity of the primers. The PCR Leishmania (Viannia) was carried 
out using the MP3H and MP1L primers that amplify a fragment of 70 bp 
of the conserved region of DNA from the minicircle of the kinetoplast 
(kDNA) of the subgenus Leishmania (Viannia)18.
Sequencing reaction: For the sequencing reaction, PCR products 
from two strains of L. infantum (MHOM/BR/1974/PP75 and MHOM/
BR/2002/LPC-RPV) were purified (Axygen Kit) and quantified using 
the Nanodrop Spectrophotometer (NanoDrop Technologies, Inc., 
Wilmington, DE, USA). Samples were diluted to a concentration of 4 
ng/μL. For sequencing, 1 μL of Big Dye Terminator v3.1, 0.4x dilution 
buffer, 0.4 mM of each primer (forward and reverse), and 2 μL of sample, 
totaling 10 μL of reaction volume were used. The reaction was carried out 
in an Applied Biosystems Thermal Cycler, with 1 cycle at 96° C for one 
min, followed by 30 cycles at 96° C for 15 sec, 56 °C for 15 sec and 60 
°C for four min, and stored at 4 °C overnight. The sequencing product was 
precipitated and purified with ethanol/EDTA according to the protocol. 
Next, it was re-suspended in 10 μL of formamide, and sequenced in an 
ABI 3500XL automated sequencer (Applied Biosystems).
Alignment of sequences: Sense and anti-sense strand sequences of 
the kDNA obtained were examined in the DNAstar Lasergene SeqMan 
v.7.00 package, which produced a consensus strand for each sample. The 
sequences were aligned using the software MEGA 532 for each sample 
that produced a single sequence kDNA. The single sequence was aligned 
using the primer-BLAST 2.0 server of the NCBI. 
RESULTS
Initially, the conditions for the PCR, including the MgCl2 
concentration, the number of cycles, and the annealing temperature for the 
primers were optimized. The annealing temperatures tested were based 
on the GC content and length of the FLC2/RLC2 primers. The condition 
in which only one fragment was amplified was chosen. The reaction 
mixture contained 0.5 μM of each primer, 1 U Taq DNA polymerase, 
2.0 mM MgCl2, 1X enzyme buffer and 2 μL of the DNA sample in a final 
volume of 25 μL. Amplification was performed at 95 °C for five min, 
35 cycles of one min at 95 °C, one min at 56 °C and one min at 72 °C, 
followed by 10 min at 72 °C. 
With regard to the sensitivity of the PCR, the FLC2/RLC2 primers 
amplified a DNA segment of 230 bp in the presence of quantities of DNA 
template equal to or greater than 0.2 fg (Fig. 2).
Analysis of DNA from different species of Leishmania (100 pg) 
and T. cruzi (100 pg) showed that only a 230 bp fragment from L. 
infantum was amplified. No fragment was observed with DNA of 
L. braziliensis isolated from dogs and humans (100 pg). In all PCR 
analyses performed in this study, only L. infantum samples showed 
the 230 bp expected amplification product indicating that there was no 
Table 1
Parasite species used in the study
Species Isolates International Code Sample Source
Leishmania (Viannia) braziliensis - serodeme I M14405 MHOM/BR/1993/M14405 1
Leishmania (Viannia) braziliensis - serodeme II M15490 MHOM/BR/1995/1077 1
Leishmania (Viannia) braziliensis - serodeme III M14046 MHOM/BR/1992/M14046 1
Leishmania (Viannia) braziliensis - serodeme VII M20932 MHOM/BR/2002/M20932 1
Leishmania (Viannia) braziliensis - serodeme I M11272 MHOM/BR/1987/M11272 1
Leishmania (Viannia) braziliensis - serodeme I M20171 CAN/BR/2001/M20171 7
Leishmania (Viannia) braziliensis M2903 MHOM/BR/1975/M2903 2
Leishmania (Leishmania) infantum CUR392 MCAN/BR/2010/CUR392 3
Leishmania (Leishmania) infantum PP75 MHOM/BR/1974/PP75 4
Leishmania (Leishmania) infantum L2906 MHOM/BR/2002/LPC-RPV 6
Leishmania (Leishmania) amazonensis M2269 MHOM/BR/1973/M2269 2
Leishmania (Viannia) lainsoni M6426 MHOM/BR/1981/M6426 2
Leishmania (Viannia) panamensis M4037 MHOM/PA/1967/BOYTON 2
Leishmania (Viannia) naiffi M5533 MDAS/BR/1979/M5533 2
Leishmania (Leishmania) major LV39 MRHO/SU/1959/P 2
Leishmania (Viannia) guyanensis M4147 MHOM/BR/1975/M4147 2
Trypanosoma cruzi Y strain 5
1: Isolates from humans with cutaneous leishmaniasis attended at Laboratório de Ensino e Pesquisa em Análises Clínicas, Universidade Estadual de Maringá, Maringá, 
Paraná and identified at Instituto Evandro Chagas, Belém, Pará. 2: Provided by Dr. Jeffrey J. Shaw, Instituto Evandro Chagas. 3: Provided by Dra. Vanete T. Soccol, 
Universidade Federal do Paraná, Curitiba, Paraná. 4: Provided by Dr. Carlos H. N. Costa, Instituto de Doenças Tropicais Natan Portella, Universidade Federal do 
Piauí, Teresina, Piauí. 5: Provided by Dr. Mônica L. Gomes, Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Maringá, Paraná. 6: 
Provided by Collection of Leishmania (CLIOC), Instituto Oswaldo Cruz. 7:Isolate from dog with cutaneous leishmaniasis attended at Laboratório de Ensino e Pesquisa 
em Análises Clínicas da Universidade Estadual de Maringá, Maringá, Paraná and identified at Instituto Evandro Chagas, Belém, Pará.
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contamination or reaction inhibition (Fig. 3). Analysis of DNA samples 
from different human patients with a confirmed diagnosis (Fig. 4A) of 
cutaneous leishmaniasis indicated that the primers showed specificity 
for L. infantum. Figure 4B shows the specificity of the primers in DNA 
samples from lesions of dogs diagnosed with cutaneous leishmaniasis 
(parasitological, serological and molecular diagnoses) and a DNA sample 
from the blood and lesion of a dog with clinically suspected VL.
The specificity of the FLC2/RLC2 primers for different isolates of 
L. infantum was also analyzed (Fig. 4C). DNA of promastigotes isolated 
from two hamsters inoculated with the blood and lesion of a dog with 
clinical suspicion of VL showed an amplified fragment of 230 bp. The 
DNA from another strain of L. infantum also showed this fragment.
No false positive result or inhibition of the reaction was observed 
in the controls.
After the two samples were sequenced, the consensus strands 
containing 230 bp were identical, and the sequence alignment to GenBank 
sequences showed homology with L. chagasi (99%), L. infantum, and 
L. donovani (89%) (Fig. 5).
DISCUSSION
In endemic areas where it is possible to find patients with different 
forms of leishmaniasis, detecting the correct parasite species of the genus 
Leishmania in a clinical sample is very important to confirm a suspected 
case of visceral or cutaneous leishmaniasis. Although no autochthonous 
cases of VL have been found in Parana, the neighboring states of Sao 
Paulo and Mato Grosso do Sul are endemic areas for VL. Therefore, 
it is necessary to standardize methodologies that allow rapid and safe 
diagnosis of VL, as well as for disease control.
A number of molecular techniques for the identification of Leishmania 
have been reported, such as RFLP-PCR (restriction fragment length 
polymorphism-PCR)6,29, RAPD (random amplified polymorphic DNA)5,26 
and multiplex-PCR. Although these methods require technical skills 
of professional and equipped laboratories in their implementation, the 
continuing search for specific targets, safer and faster molecular diagnosis 
seems to be more advantageous than using conventional techniques.
The application of PCR in the identification of L. infantum has 
great potential as a valuable tool in the detection of parasite DNA. 
PCR can identify the species of parasite involved, and is more sensitive 
than microscopy and serology1,28. Under the conditions used here, the 
standardization of PCR with FLC2/RLC2 primers showed high specificity 
and sensitivity, confirming the results obtained in the primer-BLAST 2.0 
software of the NCBI. 
The sensitivity obtained (0.2 fg) was similar to the related by 
OLIVEIRA et al.25 (2 fg) and DE BRUJIN & BARKER11 (1 fg) but it 
was higher than the one related by SILVEIRA NETO et al.31 (1 pg/μL) in 
a PCR for L. infantum. The high sensitivity was checked by the positive 
results obtained with low concentrations of DNA from L. infantum, 
demonstrating the ability to detect parasite DNA in peripheral blood 
and lesions, even in situations where the number of parasites is low. 
The primers were specific for L. infantum, since they amplify a 230 bp 
fragment of DNA only from L. infantum. The several different species 
Fig. 2 - Gel showing the analytical sensitivity of the 230 bp fragment of the kDNA of 
Leishmania infantum. The PCR with FLC2/RLC2 primers was carried out using as template 
the serially diluted DNA extracted from promastigotes of L. infantum (MHOM/BR/1974/
PP75). M, 100 bp molecular marker.
Fig. 3 - Gel showing specificity of the 230 bp fragment of the kDNA of Leishmania infantum.
The PCR with FLC2/RLC2 primers was carried out using as template the DNA extracted 
from promastigotes of Leishmania species (100 pg), epimastigotes of T. cruzi (100 pg) and 
L. braziliensis isolates from humans and dogs (100 pg). kDNA, kinetoplast DNA; M, 100 
bp molecular marker.  Panel A. Lane 1: L. amazonensis; Lane 2: L. lainsoni; Lane 3: L. 
panamensis; Lane 4: L. guyanensis; Lane 5: L. braziliensis (MHOM/BR/1987/M11272); Lane 
6: L. infantum (MHOM/BR/1974/PP75); Lane 7: negative control (water).  Panel B. Lane 1: 
L. naiffi; Lane 2: L. major; Lane 3: T. cruzi; Lane 4: L. infantum (MHOM/BR/1974/PP75); 
Lane 5: negative control (water). Panel C. Lane 1: L. braziliensis (CAN/BR/2001/M20171) 
isolated from dog (serodeme I); Lane 2: L. braziliensis (MHOM/BR/1993/M14405) isolated 
from human (serodeme I); Lane 3: L. braziliensis isolated from human (serodeme II); Lane 
4: L. braziliensis isolated from human (serodeme III); Lane 5: L. braziliensis isolated from 
human (serodeme VII); Lane 6: L. braziliensis (MHOM/BR/1987/M11272) isolated from 
human (serodeme I); Lane 7: L. infantum (MHOM/BR/1974/PP75).
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of Leishmania and serodemes of L. braziliensis tested did not show 
any amplification. The sequenced fragment showed homology with the 
L. chagasi (99%), L. infantum and L. donovani (89%) available in the 
GenBank. The high specificity of the FLC2/RLC2 primers could also 
be seen in the clinical samples from dogs and humans diagnosed with 
cutaneous leishmaniasis.
MOREIRA et al.23 compared the effectiveness of parasitological, 
immunological and molecular methods for diagnosing dogs with different 
clinical signs of VL. In samples of lymph-node aspirates from dogs, PCR 
showed 100% sensitivity in symptomatic, 96% in mildly symptomatic, 
and 95.5% in asymptomatic dogs. According to QUARESMA et al.29, 
in canine visceral leishmaniasis (CVL), PCR can detect infection even 
when conventional tests fail to diagnose the disease. QUARESMA et 
al.29 suggested PCR as a method for detection of CVL since it is highly 
reliable, sensitive and reproducible, requires a relatively short time for 
assay, and can turn into a valuable tool for epidemiological surveillance 
in endemic areas. 
ANTINORI et al.4 compared conventional tests with PCR on 
peripheral blood samples and bone-marrow aspirates from patients 
with VL who were infected, or not, with HIV, and reported that PCR 
showed 98.5% sensitivity in peripheral blood and 95.7% in bone-marrow 
aspirates. ALAM et al.1 performed PCR on DNA extracted from blood 
collected on filter paper, and detected parasites in 38 of 39 samples 
tested, in contrast to direct microscopy, which gave positive results for 
only 66.7% of the samples. BRUSTOLONI et al.9 extracted DNA from 
histological sections of patients with positive parasitological diagnoses 
for VL, and the PCR showed 94.8% sensitivity. 
In this study, PCR with FLC2/RLC2 primers proved to be a reliable 
tool for the detection of DNA from L. infantum. Showing high sensitivity 
and specificity, PCR with FLC2/RLC2 primers detected the parasite in 
clinical samples of peripheral blood and lesions. In addition, this method 
does not involve laborious, invasive or complex procedures.
RESUMO
Novos iniciadores para detecção de Leishmania infantum pela 
reação em cadeia da polimerase 
Leishmania infantum causa leishmaniose visceral (LV) no Novo 
Mundo. O diagnóstico de LV é confirmado por testes parasitológicos e 
sorológicos, os quais nem sempre são sensíveis ou específicos. Nosso 
objetivo foi desenhar novos iniciadores para realizar uma Reação em 
Cadeia da Polimerase (PCR) para detecção de L. infantum. Sequências do 
DNA do minicírculo do cinetoplasto (kDNA) foram obtidos do GenBank, 
e os iniciadores FLC2/RLC2 foram desenhados. Amostras de DNA de L. 
infantum, Leishmania amazonensis, Leishmania braziliensis, Leishmania 
guyanensis, Leishmania naiffi, Leishmania lainsoni, Leishmania 
panamensis, Leishmania major e Trypanosoma cruzi foram usados 
para padronizar a PCR. PCR com iniciadores FLC2/RLC2 amplificou 
um fragmento de 230 pb e detectou 0,2 fg de DNA de L. infantum. 
Das espécies de parasitos analisadas, somente DNA de L. infantum 
foi amplificado. Após sequenciamento, o fragmento foi analisado no 
GenBank, que mostrou homologia com L. infantum. Em análises de 
amostras de sangue e lesão de cão com suspeita clínica de LV, a PCR 
detectou DNA de L. infantum. Em amostras de lesão de humanos e cães 
com leishmaniose cutânea, a PCR foi negativa. A PCR padronizada com 
os iniciadores FLC2/RLC2 mostrou alta sensibilidade e especificidade, 
sendo técnica promissora para o diagnóstico de LV. 
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Lane 7: L. infantum (MHOM/BR/1974/PP75). Panel C. Lane 1: DNA from promastigotes 
isolated from a hamster inoculated with tissues from the lesion of a dog with clinical suspicion 
of VL (Isolate I); Lane 2: DNA from promastigotes isolated from a hamster inoculated with the 
blood sample of a dog with clinical suspicion of VL (Isolate II); Lane 3: L. infantum (MCAN/
BR/2010/CUR392); Lane 4: L. infantum (MHOM/BR/1974/PP75).
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Fig. 5 - Alignment of PCR product obtained showing homology with DNA minicircle kinetoplast (kDNA) of isolates from GenBank. Including L. chagasi (GenBank accession No. 
AF308682.1|AF308682), L. infantum strain IranJWinf (GenBank accession No. AB678348.1), L. infantum strain MCAN/ES/98/10445 (GenBank accession No. EU437407.1) and L. donovani 
(GenBank accession No. L19877.1), respectively. Underlined nucleotides represent additional bases and bolded positions represent different bases.
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